menu search

Aclaris Therapeutics to Participate in Two June Healthcare Investor Conferences

Aclaris Therapeutics to Participate in Two June Healthcare Investor Conferences
WAYNE, Pa., June 02, 2023 (GLOBE NEWSWIRE) — Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, today announced that members of the Aclaris management team will participate in two healthcare investor conferences in June. Management will participate in a fireside chat during the 2023 Jefferies […] The post Aclaris Therapeutics to Participate in Two June Healthcare Investor Conferences... Read More
Posted: Jun 2 2023, 11:00
Author Name: forextv
Views: 081368

Search within

Pages Search Results: